Biography
Selected Publications
Contact Information

Biography

Deborah McMahon, M.D. is an Associate Professor of Medicine in the Division of Infectious Diseases, director of its HIV-AIDS Unit, and has a secondary appointment in the Department of Infectious Diseases and Microbiology in the Graduate School of Public Health. She is the Medical Director of the AIDS Clinical Research Unit, which conducts ACTG and industry sponsored clinical trials. She works closely with Dr. Mellors and also sees patients in the HIV Primary Care Center. Dr. McMahon is the Director of HRSA-funded Pitt HIV Early Intervention Project, which provides testing and counseling services as well as primary care services to over 900 HIV-infected men and women in Western Pennsylvania. She interacts extensively with fellows in the clinical care of AIDS patients and in the implementation of AIDS clinical trials.

Selected Publications

1. Harrold SM, Wang G, McMahon, DK, Riddler, SA, Mellors JW, Becker JT, Caldararo R, Reinhart TA, Achim CL, and Wiley CA. Recovery of replication-competent HIV-1 infected circulating monocytes from individuals receiving antiretroviral therapy. AIDS Res Hum Retroviruses 2002; 18:6:00-00.
   
   
2. McMahon DK, Lederman M, Haas DW, Haubrich R, Stanford J, Cooney E, Horton J, Kelleher D, Ross L, Cutrell A, Lee D, Spreen W, Mellors JW. Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy naïve HIV-1 infected adults. Antiretroviral Therapy 2001; 6:105-114.
   
   
3. Collier AC, Kalish LA, Busch MP, Gernsheimer T, Assmann SF, Lane TA, Asmuth DM, Lederman MM, Murphy EL, Kumar P, Kelley M, Flanigan TP, McMahon DK, Sacks HS, Kennedy MS, Holland PV for the Viral Activation Transfusion Study Group. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection. JAMA 2001; 285:1592-1601.
   
   
4. Kalish LA, Collier AC, Flanigan TP, Kumar PV, and the Viral Activation Transfusion Study Group (VATS) (McMahon DK is a member of the VATS). Plasma human immunodeficiency virus type 1 (HIV-1) RNA load in men and women with advanced HIV-1 disease. J Infect Dis 2000; 182:603-606.
   
   
5. Gulick RM, Mellors JW, Havlir D, Eron JJ, Meibohm A, Condra JH, Valentine FT, McMahon D, Gonzales C, Jonas L, Emini Lamivudine. Ann Intern Med 2000; 133:35-39.
   
   
6. Rinaldo CR, Huang X-L, Fan Z, Margolick JB, Borowski L, Hoji A, Kalinyak C, McMahon DK, Riddler SA, Hildebrand WH, Day RB, Mellors JW. Anti-human immunodeficiency virus type 1 (HIV-1) CD8+ T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1 infected patients with advanced immunodeficiency. J Virology 2000; 5:4127-4138.
   
   
7. Rinaldo CR, Liebmann JM, Huang X-L, Fan Z, Al-Shboul Q, McMahon DK, Day RD, Riddler SA, Mellors JW. Prolonged suppression of HIV-1 viremia results in profound, delayed enhancement of CD4+ T-cell reactivity to mitogen and microbial antigens, but not to HIV-1 antigens. J Infect Dis 1999; 179:329-336.
   
   
8. Cameron DW, Japour AJ, Xu Y, Hsu A, Cohen C, Farthing C, Follansbee S, Markowitz M, Mellors JW, Poretz D, Angel JB, Ho D, McMahon DK, Devanarayan V, Rode R, Salgo M, Kempf D, Granneman R, Leonard JM, Sun E. Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS 1999; 13:213-224.
   
   
9. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon DK, Valentine FT, Jonas L, Meibohm A, Holder D, Schleif WA, Condra JH, Emini EA, Issacs R, Chodakewitz JA, Richman DD. A randomized study of concomitant versus sequential three-drug antiretroviral therapy in HIV-infected adults. JAMA 1998; 280:35-41.